Guido Di Dalmazi

22PUBLICATIONS
56CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersRespiratory diseasesCellular immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (22)

|Aug 13, 2026
Pan-CDK and PLK1 inhibitors as a novel approach for targeted treatment of adrenocortical carcinomas.

|Aug 11, 2026
Impact of adrenalectomy on metabolic alterations and quality of life in mild autonomous cortisol secretion: results from the randomized CHIRACIC trial.

|Mar 06, 2026
Clinical predictors of outcome in advanced adrenocortical carcinoma: a multicenter international ENSAT study.

Alessandra Mangone, Barbara Altieri, Emanuele Ferrante

|Sep 29, 2025
Redefining hemodynamic instability in pheochromocytoma surgery through latent class analysis.

Laura Alberici, Claudio Ricci, Valentina Vicennati

|Jul 14, 2025
Impact of old and current immunoassays on the 1 mg overnight dexamethasone suppression test: comparison with LC-MS/MS.

Laura Rotolo, Greta Galante, Kimberly Coscia

|Nov 11, 2024
Therapeutic potential of targeting the FLNA-regulated Wee1 kinase in adrenocortical carcinomas.

Emanuela Esposito, Giusy Marra, Rosa Catalano

Pageof 4

Frequent Collaborators

3 joint publications

Giovanna Mantovani

3 joint publications

Alessandra Mangone

3 joint publications

Emanuele Ferrante

3 joint publications

Uberto Pagotto